Skip to main content
Top
Published in: Nuclear Medicine and Molecular Imaging 3/2013

01-09-2013 | Case Report

Unsuspected Active Sarcoidosis Diagnosed by 18F-FDG PET/CT During the Search for a Primary Tumour in a Patient with Bone Lesions

Authors: Federico Caobelli, Sara Vincenzina Gabanelli, Antonio Brucato, Claudio Pizzocaro, Alberto Soffientini, Raffaele Giubbini, Ugo Paolo Guerra

Published in: Nuclear Medicine and Molecular Imaging | Issue 3/2013

Login to get access

Abstract

Sarcoidosis is a systemic chronic inflammatory disease of unknown aetiology, characterised by granulomatous lesions with heterogeneous clinical manifestations affecting multiple organs and tissues. Although the respiratory system is most commonly affected, the disease may also present with bone lesions. We report the case of a 31-year-old woman who presented with low back pain and no history of cancer and who was found to have suspicious lesions involving the entire spine on magnetic resonance imaging (MRI). The patient underwent 18F-fluorodeoxyglucose (FDG) PET/CT to search for a primary tumour and for staging purposes. 18F-FDG PET/CT revealed a pattern of hypermetabolic activity in widespread skeletal lesions and in a single left cervical lymph node. The primary tumour was not found, thus suggesting a haematologic disorder. Subsequent biopsies of a cervical lymph node and of bone tissue from L4 revealed active sarcoidosis with no evidence of cancer. This underlines the importance of considering all alternatives when hypermetabolic lesions are found on 18F-FDG PET/CT. Furthermore, 18F-FDG PET can be very useful to indicate accessible sites for guiding fine-needle aspiration cytology (FNAC).
Literature
2.
go back to reference Franco M, Passeron C, Tieulie N, Verdier JF, Benisvy D. Long-term radiographic follow-up in a patient with sclerotic sarcoidosis of the spine and pelvis. Rev Rheum Engl Ed. 1998;65:586–90. Franco M, Passeron C, Tieulie N, Verdier JF, Benisvy D. Long-term radiographic follow-up in a patient with sclerotic sarcoidosis of the spine and pelvis. Rev Rheum Engl Ed. 1998;65:586–90.
3.
go back to reference Jelinek JS, Mark AS, Barth WF. Sclerotic lesions of the cervical spine in sarcoidosis. Skeletal Radiol. 1998;27:702–4.PubMedCrossRef Jelinek JS, Mark AS, Barth WF. Sclerotic lesions of the cervical spine in sarcoidosis. Skeletal Radiol. 1998;27:702–4.PubMedCrossRef
4.
go back to reference Talmi D, Smith HS, Mulligan ME. Central skeletal sarcoidosis mimicking metastatic disease. Skeletal Radiol. 2008;37:757–61.PubMedCrossRef Talmi D, Smith HS, Mulligan ME. Central skeletal sarcoidosis mimicking metastatic disease. Skeletal Radiol. 2008;37:757–61.PubMedCrossRef
5.
go back to reference Jain V, Hasselquist S, Delaney MD. PET scanning in sarcoidosis. Ann N Y Acad Sci. 2011;1228:46–58.PubMedCrossRef Jain V, Hasselquist S, Delaney MD. PET scanning in sarcoidosis. Ann N Y Acad Sci. 2011;1228:46–58.PubMedCrossRef
6.
go back to reference Zhuang H, Alavi A. 18-Fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation. Semin Nucl Med. 2002;32:47–9.PubMedCrossRef Zhuang H, Alavi A. 18-Fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation. Semin Nucl Med. 2002;32:47–9.PubMedCrossRef
7.
go back to reference Khiar A, Duet M, Ammari S, Brouland JP, Lioté F, Paycha F. Disseminated bone involvement in systemic sarcoidosis mimicking bone metastases. A multimodality imaging approach. Joint Bone Spine. 2011;78:216–7.PubMedCrossRef Khiar A, Duet M, Ammari S, Brouland JP, Lioté F, Paycha F. Disseminated bone involvement in systemic sarcoidosis mimicking bone metastases. A multimodality imaging approach. Joint Bone Spine. 2011;78:216–7.PubMedCrossRef
8.
go back to reference Mostard RL, Prompers L, Weijers RE, van Kroonenburgh MJ, Wijnen PA, Geusens PP, et al. F-18 FDG PET/CT for detecting bone and bone marrow involvement in sarcoidosis patients. Clin Nucl Med. 2012;37:21–5.PubMedCrossRef Mostard RL, Prompers L, Weijers RE, van Kroonenburgh MJ, Wijnen PA, Geusens PP, et al. F-18 FDG PET/CT for detecting bone and bone marrow involvement in sarcoidosis patients. Clin Nucl Med. 2012;37:21–5.PubMedCrossRef
9.
go back to reference Ambrosini V, Fasano L, Zompatori M, Nanni C, Allegri V, Nava S, et al. 18F-FDG PET/CT detects systemic involvement in sarcoidosis. Eur J Nucl Med Mol Imaging. 2011;38:2102.PubMedCrossRef Ambrosini V, Fasano L, Zompatori M, Nanni C, Allegri V, Nava S, et al. 18F-FDG PET/CT detects systemic involvement in sarcoidosis. Eur J Nucl Med Mol Imaging. 2011;38:2102.PubMedCrossRef
10.
go back to reference Kaira K, Oriuchi N, Otani Y, Yanagitani N, Sunaga N, Hisada T, et al. Diagnostic usefulness of fluorine-18-alpha-methyltyrosine positron emission tomography in combination with 18F-fluorodeoxyglucose in sarcoidosis patients. Chest. 2007;131:1019–27.PubMedCrossRef Kaira K, Oriuchi N, Otani Y, Yanagitani N, Sunaga N, Hisada T, et al. Diagnostic usefulness of fluorine-18-alpha-methyltyrosine positron emission tomography in combination with 18F-fluorodeoxyglucose in sarcoidosis patients. Chest. 2007;131:1019–27.PubMedCrossRef
11.
go back to reference Montini KM, Tulchinsky M. False-positive bone metastases on PET/CT secondary to sarcoidosis in a patient with rectal cancer. Clin Nucl Med. 2012;37:307–10.PubMedCrossRef Montini KM, Tulchinsky M. False-positive bone metastases on PET/CT secondary to sarcoidosis in a patient with rectal cancer. Clin Nucl Med. 2012;37:307–10.PubMedCrossRef
Metadata
Title
Unsuspected Active Sarcoidosis Diagnosed by 18F-FDG PET/CT During the Search for a Primary Tumour in a Patient with Bone Lesions
Authors
Federico Caobelli
Sara Vincenzina Gabanelli
Antonio Brucato
Claudio Pizzocaro
Alberto Soffientini
Raffaele Giubbini
Ugo Paolo Guerra
Publication date
01-09-2013
Publisher
Springer Berlin Heidelberg
Published in
Nuclear Medicine and Molecular Imaging / Issue 3/2013
Print ISSN: 1869-3474
Electronic ISSN: 1869-3482
DOI
https://doi.org/10.1007/s13139-013-0203-y

Other articles of this Issue 3/2013

Nuclear Medicine and Molecular Imaging 3/2013 Go to the issue